Neuroregulatory Peptide
Active Substance: Delta Sleep-Inducing Peptide (DSIP)
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
Form: Lyophilized Powder
πΊπΈ USA Domestic:Β 2β7 Days Delivery
π International:Β 5β20 Days Delivery
DSIP 10 mg by Dragon Pharma is a research peptide commonly discussed in protocols related to sleep quality, recovery, and stress regulation. Short for Delta Sleep-Inducing Peptide, DSIP has attracted long-term interest in peptide research because of its association with deep sleep patterns, circadian rhythm support, and overall recovery capacity.
For athletes, bodybuilders, and high-stress users, sleep quality can directly affect recovery, hormonal balance, focus, and training output. For users looking to buy DSIP by Dragon Pharma, product quality, sterile handling, and consistent sourcing are all important when evaluating a peptide for research purposes.
DSIP (Delta Sleep-Inducing Peptide) is a synthetic nonapeptide composed of 9 amino acids. It has been investigated for its potential role in sleep regulation, stress response, and neuroendocrine balance.
Unlike traditional sleep aids that work through sedative action, DSIP is generally studied for its possible influence on natural sleep architecture and deeper stages of restorative sleep.
In performance-focused communities, DSIP is most often researched for its relationship to sleep quality and overnight recovery. Since recovery processes are closely tied to deep sleep, peptides associated with sleep architecture have become increasingly relevant in physique and training-focused protocols.
For more background on the peptide's research history, you can refer to this PubMed study on DSIP and sleep regulation.
DSIP has been studied in relation to sleep regulation, stress adaptation, and neuroendocrine activity. Research interest has included its potential role in delta sleep support, HPA-axis modulation, and circadian function.
Its profile has also made it relevant in recovery-focused discussions among athletes and bodybuilders who place a high value on deep sleep as a foundation for muscle repair, nervous system recovery, and daytime performance.
Note: DSIP is intended for research purposes only. The following reflects common protocol patterns and provided context rather than medical advice.
DSIP is commonly researched in low-dose evening protocols, often administered 30-60 minutes before sleep. Example protocol ranges may include:
The 10 mg vial is commonly reconstituted with 2 mL of bacteriostatic water, producing a concentration of 5 mg/mL. At that concentration, a 200 mcg dose equals 0.04 mL, or 4 units on a U-100 insulin syringe.
Female research protocols often use slightly lower nightly amounts, frequently in the range of 50-200 mcg, depending on protocol design and response. Lower maintenance use a few times per week is also common in anecdotal research discussions.
DSIP is known for having a short circulating half-life, but research discussions often describe effects that may extend beyond the immediate dosing window. This is one reason intermittent use is sometimes referenced in DSIP-related protocols.
DSIP is generally discussed as well tolerated in research settings. When side effects are mentioned, they are often mild and may include vivid dreams, temporary drowsiness, headache, or minor injection-site irritation.
Because DSIP is frequently used in evening protocols, accurate timing and conservative dosing are commonly emphasized when evaluating tolerance.
DSIP should not be used by pregnant or nursing women. Individuals with significant psychiatric or neurological conditions should use caution when considering compounds that may affect sleep or central nervous system regulation. Because DSIP may overlap with other sleep-related or CNS-active compounds, careful protocol planning is advised. Always use sterile technique and keep out of reach of children.
Excessive dosing may increase the risk of prolonged drowsiness, vivid dreaming, temporary disruption of normal sleep patterns, or headache. If accidental overuse occurs, discontinue use and seek medical advice.
DSIP is often researched alongside other peptides connected to sleep, circadian support, or stress management. Common combinations include:
These combinations are typically explored by users interested in sleep quality, recovery, and improved resilience during demanding training periods or irregular schedules.
Dragon Pharma presents DSIP in a sterile 2 mL vial containing 10 mg of lyophilized powder. The freeze-dried format helps preserve stability before reconstitution and supports accurate dose preparation.
Store the lyophilized vial in a cool, dry place away from direct light and moisture, ideally at 2-8Β°C. After reconstitution with bacteriostatic water, keep refrigerated and use within 2-3 weeks for best stability. Do not freeze.
This product is intended for laboratory research and analytical purposes only. Not for human consumption. Always verify the legality of this compound in your jurisdiction before purchase.
DSIP is a research peptide studied for sleep quality, recovery, circadian rhythm support, and stress regulation. It is commonly explored in protocols focused on deep sleep and overnight recovery.
DSIP is studied for its potential influence on natural sleep architecture, stress response, and neuroendocrine balance. Research interest often focuses on its relationship to deeper sleep stages and recovery-related regulation.
Yes, DSIP is known among athletes, bodybuilders, and fitness-focused users who prioritize sleep quality and recovery. It is often researched as part of nighttime protocols intended to support deeper recovery during demanding training periods.
To reconstitute the 10 mg vial, researchers commonly add 2 mL of bacteriostatic water and gently swirl until fully dissolved. This yields a concentration of 5 mg/mL and allows precise low-dose measurement with a U-100 insulin syringe.
To help verify authenticity, buy only from trusted sources that maintain proper storage conditions and provide clear product labeling. Dragon Pharma peptides should arrive in properly labeled sterile vials with batch-related information when available.
Please log in to write DSIP 10 mg review.
Melanotropin Peptide
Active Substance: Melanotan 2
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
Laboratory Tested: View Lab Result
Copper Binding Peptide
Active Substance: GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex)
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (50 mg/vial)
Form: Lyophilized Powder
Laboratory Tested: View Lab Result
πΊπΈ USA Domestic:Β 2β7 Days Delivery
π International:Β 5β20 Days Delivery